LOS ANGELES: Two years after a double mastectomy, actress Angelina Jolie has had her ovaries and fallopian tubes removed to avoid the risk of ovarian cancer, a move cancer experts described as courageous and influential.

Cancer specialists praised the Hollywood star’s second public revelation for increasing awareness about genetic testing and prophylactic surgery to reduce the risk of breast and ovarian cancer.

“My hat is off to her,” said Dr. Robert DeBernardo, a gynecologic oncologist at the Cleveland Clinic’s Ob/Gyn & Women’s Health Institute. “She is doing a lot of good for women worldwide by raising awareness of BRCA testing and options women have.”

“It was incredibly courageous,” said Dr. Marleen Meyers, an assistant professor of medicine at NYU Langone’s Laura and Isaac Perlmutter Cancer Center.

Jolie said she went public with her decision so women would know about options available to them.

The surgery showed no signs of cancer, Jolie said, but it triggered early menopause, and she will not be able to have more children.

Research showed that her 2013 decision to have a double mastectomy to cut her risk of breast cancer increased demand for genetic testing in what was dubbed the “Angelina Effect.”

DeBernardo’s colleague, gynecologic oncologist Dr. Jason Knight, said he hoped Jolie’s latest announcement would spark important discussions among patients and their families and improve access to risk-reducing surgery for people who would benefit from it. “It is a very personal decision and one that should be made with good medical information,” he said.